These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 25723113

  • 1. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 2. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI.
    Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 4. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.
    Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604
    [Abstract] [Full Text] [Related]

  • 5. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS, Lee YH, Jin YT, Kuo YJ.
    Virchows Arch; 2020 Oct 15; 477(4):581-592. PubMed ID: 32383006
    [Abstract] [Full Text] [Related]

  • 7. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z.
    Cancer Med; 2019 Dec 15; 8(17):7322-7329. PubMed ID: 31609094
    [Abstract] [Full Text] [Related]

  • 8. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
    Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ.
    J Transl Med; 2014 Oct 25; 12():299. PubMed ID: 25343854
    [Abstract] [Full Text] [Related]

  • 9. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
    Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D.
    Clin Cancer Res; 2013 Jan 15; 19(2):480-90. PubMed ID: 23186780
    [Abstract] [Full Text] [Related]

  • 10. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I.
    Histopathology; 2013 Aug 15; 63(2):250-62. PubMed ID: 23738717
    [Abstract] [Full Text] [Related]

  • 11. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS.
    Histopathology; 2012 Oct 15; 61(4):629-43. PubMed ID: 22882517
    [Abstract] [Full Text] [Related]

  • 12. ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing.
    Ferguson DC, Momeni Boroujeni A, Zheng T, Mohanty AS, Ho AL, Arcila ME, Ross DS, Dogan S.
    Mod Pathol; 2022 Jul 15; 35(7):895-902. PubMed ID: 34963694
    [Abstract] [Full Text] [Related]

  • 13. Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland.
    Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, Sung YS, Chen CL, Assaad A, Oliai BR, Antonescu CR.
    Am J Surg Pathol; 2018 Apr 15; 42(4):442-452. PubMed ID: 29443014
    [Abstract] [Full Text] [Related]

  • 14. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
    Rooper LM, Gagan J, Bishop JA.
    Head Neck Pathol; 2022 Dec 15; 16(4):1063-1072. PubMed ID: 35794510
    [Abstract] [Full Text] [Related]

  • 15. Pure Apocrine Intraductal Carcinoma of Salivary Glands: Reassessment of Molecular Underpinnings and Behavior.
    Delfin L, Doff JJ, Gagan J, Flack A, Krane JF, Jo VY, Torell AG, Palsgrove D, Bishop JA.
    Head Neck Pathol; 2024 Jun 27; 18(1):58. PubMed ID: 38935197
    [Abstract] [Full Text] [Related]

  • 16. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
    Udager AM, Chiosea SI.
    Head Neck Pathol; 2017 Sep 27; 11(3):288-294. PubMed ID: 28321773
    [Abstract] [Full Text] [Related]

  • 17. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
    Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.
    Hum Pathol; 2019 Jun 27; 88():66-77. PubMed ID: 30946933
    [Abstract] [Full Text] [Related]

  • 18. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW.
    Clin Cancer Res; 2016 Dec 15; 22(24):6061-6068. PubMed ID: 27334835
    [Abstract] [Full Text] [Related]

  • 19. Low-grade Apocrine Intraductal Carcinoma: Expanding the Morphologic and Molecular Spectrum of an Enigmatic Salivary Gland Tumor.
    Bishop JA, Gagan J, Krane JF, Jo VY.
    Head Neck Pathol; 2020 Dec 15; 14(4):869-875. PubMed ID: 31989433
    [Abstract] [Full Text] [Related]

  • 20. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark JR, Gupta R.
    Head Neck; 2016 Apr 15; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.